• Explore /
  • Poster
  • / Patient-reported outcomes (PROs) comparison of 5-FU and capecitabine (cape) with concurrent radiotherapy (RT) for neoadjuvant treatment of rectal cancer: Results of NSABP R-04.

Patient-reported outcomes (PROs) comparison of 5-FU and capecitabine (cape) with concurrent radiotherapy (RT) for neoadjuvant treatment of rectal cancer: Results of NSABP R-04.

Abstract Poster

Authors

null

Greg Yothers

NSABP Biostatistical Center and University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA

Greg Yothers , Patricia A. Ganz , Samia H. Lopa , Clifford Y. Ko , D. Lawrence Wickerham , Norman Wolmark

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session C: Cancers of the Colon and Rectum

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Prevention, Diagnosis, and Screening

Clinical Trial Registration Number

NCT00058474

Citation

J Clin Oncol 30, 2012 (suppl 4; abstr 391)

DOI

10.1200/jco.2012.30.4_suppl.391

Abstract #

391

Poster Bd #

A10

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.

Total neoadjuvant therapy (TNT) for locally advanced rectal cancer (LARC): Real-world experience from a tertiary Asian cancer center.

First Author: Meng Wang

First Author: Simon Gollins

First Author: Geoffrey Yuyat Ku

First Author: Darren Cowzer